These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9669267)

  • 61. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
    Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
    J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sotalol in treatment of pediatric cardiac arrhythmias.
    Celiker A; Ayabakan C; Ozer S; Ozme S
    Pediatr Int; 2001 Dec; 43(6):624-30. PubMed ID: 11737739
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Is either sotalol or amiodarone more effective than digoxin for converting patients with new-onset atrial fibrillation (AF) to sinus rhythm within 48 hours?
    Forney AJ; Schooff M
    J Fam Pract; 2000 Nov; 49(11):982. PubMed ID: 11093561
    [No Abstract]   [Full Text] [Related]  

  • 64. Sotalol in the treatment of fetal dysrhythmias.
    Oudijk MA; Michon MM; Kleinman CS; Kapusta L; Stoutenbeek P; Visser GH; Meijboom EJ
    Circulation; 2000 Jun; 101(23):2721-6. PubMed ID: 10851210
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differential effect of some antiarrhythmic drugs in right- or left-sided aconitine-induced experimental atrial arrhythmias.
    Gautam CS; Lal R; Pandhi P; Sharma PL
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):91-3. PubMed ID: 3586773
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Arrhythmias in pregnancy. How and when to treat?].
    Flores JR; Márquez MF
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-24-S2-31. PubMed ID: 17972373
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intravenous Sotalol in the Young: Safe and Effective Treatment With Standardized Protocols.
    Borquez AA; Aljohani OA; Williams MR; Perry JC
    JACC Clin Electrophysiol; 2020 Apr; 6(4):425-432. PubMed ID: 32327076
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sotalol for cardiac arrhythmias.
    Med Lett Drugs Ther; 1993 Apr; 35(893):27-8. PubMed ID: 8450806
    [No Abstract]   [Full Text] [Related]  

  • 69. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ
    Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
    Wiesfeld AC; Ansink JM; van Veldhuisen DJ; van Gelder IC
    Int J Cardiol; 2006 Feb; 107(1):140-1. PubMed ID: 15990183
    [No Abstract]   [Full Text] [Related]  

  • 71. Safety and feasibility of a clinical pathway for the outpatient initiation of antiarrhythmic medications in patients with atrial fibrillation or atrial flutter.
    Hauser TH; Pinto DS; Josephson ME; Zimetbaum P
    Am J Cardiol; 2003 Jun; 91(12):1437-41. PubMed ID: 12804730
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Sotalol-induced torsade de pointes: management with magnesium infusion.
    Arstall MA; Hii JT; Lehman RG; Horowitz JD
    Postgrad Med J; 1992 Apr; 68(798):289-90. PubMed ID: 1409197
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Drug therapy of tachycardic atrial arrhythmias].
    Wietholt D; Gülker H
    Med Klin (Munich); 1997 Apr; 92(4):197-201. PubMed ID: 9221300
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Am J Cardiol; 2017 May; 119(9):1366-1370. PubMed ID: 28283175
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The role of drugs in the long-term management of cardiac arrhythmias].
    Huikuri H
    Duodecim; 1992; 108(13):1158-60. PubMed ID: 1366068
    [No Abstract]   [Full Text] [Related]  

  • 76. Dofetilide: a new class III antiarrhythmic agent.
    Roukoz H; Saliba W
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):9-19. PubMed ID: 17187453
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Reversible vestibular dysfunction secondary to sotalol use.
    Kapa S; Nagel JJ; Jahangir A; Asirvatham SJ
    J Interv Card Electrophysiol; 2010 Jan; 27(1):17-21. PubMed ID: 19844783
    [No Abstract]   [Full Text] [Related]  

  • 78. Effect of Sotalol on clinical arrhythmias.
    Prakash R; Parmley WW; Allen HN; Matloff JM
    Am J Cardiol; 1972 Mar; 29(3):397-400. PubMed ID: 4110596
    [No Abstract]   [Full Text] [Related]  

  • 79. Dofetilide: a review of its use in atrial fibrillation and atrial flutter.
    McClellan KJ; Markham A
    Drugs; 1999 Dec; 58(6):1043-59. PubMed ID: 10651390
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D; Rowland E; O'Nunain S; Shakespeare CF; Poloniecki J; Camm AJ
    Eur Heart J; 1995 Dec; 16(12):1930-5. PubMed ID: 8682029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.